Categories: News

NYSE Content Advisory: Pre-Market Update + Crypto Infrastructure Company BitGo Rises 2.7% in NYSE Debut

NEW YORK, Jan. 23, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on January 23rd

- Advertisement -
  • U.S. equities are mixed Friday after two days of gains driven by easing geopolitical concerns; BitGo shares rose 2.7% in their NYSE debut, with COO Jody Mettler saying this is “just the beginning” for the company.
  • Viewers can tune into NYSE Live at 9 a.m. ET on the NYSE TV app, where ICE VP of Strategic Initiatives Michael Blaugrund will discuss the newly announced NYSE tokenized securities platform enabling 24/7 trading of U.S. equities and ETFs.
  • Target announced new board appointments as it enters a new growth phase under incoming CEO Michael Fiddelke: former Nike Chief Innovation Officer John Hoke joins March 1, and former HanesBrands CEO Steve Bratspies joins April 1.

Opening Bell
Rithm Capital rings the NYSE Opening Bell

- Advertisement -

Closing Bell
Zeta Global celebrates the full beta launch of Athena

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2868097/NYSE_Market_Update_Jan_23.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5732218/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update—crypto-infrastructure-company-bitgo-rises-2-7-in-nyse-debut-302668981.html

- Advertisement -

Recent Posts

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading…

2 hours ago

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

February 12, 2026 21:18 ET  | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., Feb. 12,…

2 hours ago

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

 US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award…

2 hours ago

Hexaware and CareInsight Announce Strategic Partnership to Accelerate AI-driven Healthcare Transformation

MUMBAI, India, Feb. 12, 2026 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a global provider of…

2 hours ago

Berlin Heals Successfully Raises Over 10M USD to Expand the New Less Invasive Approach to More Heart Failure Patients

ZUG, Switzerland, Feb. 12, 2026 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company focused on…

2 hours ago

Enfinity Global Expands Bond Facility to the US with Eiffel Investment Group to $183 Million to Support Growth

MIAMI, Feb. 12, 2026 /PRNewswire/ -- Enfinity Global Inc., a leader in renewable energy, today…

3 hours ago